The Oncosearch | Oncotarget

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Till Braun, Hanna Klepzig, Marco Herling

Published Feb 28, 2023 · Vol. 14, No. 1 · pp. 395-397

Keywords: T-PLL, AGO2, microRNA

Proof-of-principle: targeted childhood leukemia prevention Editorial

César Cobaleda, Manuel Ramírez-Orellana, Carolina Vicente-Dueñas, Andreas Weiss, Kim E. Nichols, Isidro Sánchez-García

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 190-192

Keywords: leukemia, infection, murine models, genetic susceptibility, prevention

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Clark G. Wang, Malalage N. Peiris, April N. Meyer, Katelyn N. Nelson, Daniel J. Donoghue

Published Feb 6, 2023 · Vol. 14, No. 1 · pp. 133-145

Keywords: oncogenic fusion protein, chromosomal translocation, glioblastoma, FGFR3-TACC3, coiled-coil

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Yang Yi, Yanqiang Li, Kaifu Chen, Qi Cao

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 127-128

Keywords: EZH2, prostate cancer, FBL, CDCA8, E2F1

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

Leo I. Gordon, Reem Karmali, Jason B. Kaplan, Rakesh Popat, Howard A. Burris III, Silvia Ferrari, Sumit Madan, Manish R. Patel, Giuseppe Gritti, Dima El-Sharkawi, F. Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P. Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch

Published Jan 20, 2023 · Vol. 14, No. 1 · pp. 57-70

Keywords: Non-Hodgkin’s lymphoma, DLBCL, relapsed/refractory, SYK inhibitor, TAK-659

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction

Yonghao Zhan, Yifan Li, Bao Guan, Xiaoying Chen, Zhicong Chen, Anbang He, Shiming He, Yanqing Gong, Ding Peng, Yuchen Liu, Zhiming Cai, Xuesong Li, Liqun Zhou

Published Jan 14, 2023 · Vol. 14, No. 1 · pp. 210-210

Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 Research Paper

Xiaofan Li, Cristina Abrahams, Abigail Yu, Millicent Embry, Robert Henningsen, Venita DeAlmeida, Shannon Matheny, Toni Kline, Alice Yam, Ryan Stafford, Trevor Hallam, Mark Lupher, Arturo Molina

Published Dec 27, 2022 · Vol. 14, No. 1 · pp. 1-13

Keywords: CD74, antibody-drug conjugate, non-Hodgkin lymphoma, xenograft models, STRO-001

Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD) Research Paper

Mamoun Younes, Lin Zhang, Baharan Fekry, Kristin Eckel-Mahan

Published Nov 26, 2022 · Vol. 13, No. 1 · pp. 1308-1313

Keywords: hepatocyte nuclear factor four alpha, steatohepatitis, immunohistochemistry, hepatocellular carcinoma, isoform

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients Research Paper

Yehia I. Mohamed, Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao, Jeffrey S. Morris, Robert A. Wolff, Khaled M. Elsayes, Rikita I. Hatia, Aliya Qayyum, Shadi M. Chamseddine, Asif Rashid, James C. Yao, Armeen Mahvash, Manal M. Hassan, Hesham M. Amin, Ahmed Omar Kaseb

Published Nov 26, 2022 · Vol. 13, No. 1 · pp. 1314-1321

Keywords: growth hormone, hepatocellular carcinoma, immunotherapy, atezolizumab, bevacizumab

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem

Published Nov 18, 2022 · Vol. 13, No. 1 · pp. 1306-1306

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Yun Peng, Jun Cao, Xiao-Yi Yao, Jian-Xin Wang, Mei-Zuo Zhong, Ping-Ping Gan, Jian-Huang Li

Published Nov 16, 2022 · Vol. 13, No. 1 · pp. 1301-1301

Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer Retraction

Yangyang Hu, Chao Deng, He Zhang, Jing Zhang, Bo Peng, Chuanyi Hu

Published Nov 16, 2022 · Vol. 13, No. 1 · pp. 1258-1258

Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention Research Paper

Gwendolyn J. McGinnis, Sarah Holden, Betty Yu, Charlton Ransom, Carolyn Guidarelli, Brian De, Kevin Diao, David Boyce, Charles R. Thomas Jr., Kerri Winters-Stone, Jacob Raber

Published Nov 5, 2022 · Vol. 13, No. 1 · pp. 1259-1270

Keywords: apoE, breast cancer, exercise intervention, fall rate, functional status

Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis Research Paper

Yuji Morine, Tohru Utsunomiya, Hisami Yamanaka-Okumura, Yu Saito, Shinichiro Yamada, Tetsuya Ikemoto, Satoru Imura, Shohei Kinoshita, Akiyoshi Hirayama, Yasuhito Tanaka, Mitsuo Shimada

Published Oct 27, 2022 · Vol. 13, No. 1 · pp. 1286-1298

Keywords: metabolomics, essential amino acid, hepatocellular carcinoma, diagnostic biomarker

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Masahiko Shibata, Kotaro Nanno, Daigo Yoshimori, Takahiro Nakajima, Makoto Takada, Takashi Yazawa, Kousaku Mimura, Norio Inoue, Takafumi Watanabe, Kazunoshin Tachibana, Satoshi Muto, Tomoyuki Momma, Yoshiyuki Suzuki, Koji Kono, Shungo Endo, Seiichi Takenoshita

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1273-1285

Keywords: MDSC, immunosuppression, Treg, TAM, cancer

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

Neal Murphy, Andrew J. Shih, Paras Shah, Oksana Yaskiv, Houman Khalili, Anthony Liew, Annette T. Lee, Xin-Hua Zhu

Published Oct 20, 2022 · Vol. 13, No. 1 · pp. 1188-1200

Keywords: muscle invasive bladder cancer, neoadjuvant chemotherapy, gene expression, molecular subtyping, canonical correlation analysis

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Ida Steiro, Esten N. Vandsemb, Samah Elsaadi, Kristine Misund, Anne-Marit Sponaas, Magne Børset, Pegah Abdollahi, Tobias S. Slørdahl

Published Oct 15, 2022 · Vol. 13, No. 1 · pp. 1175-1186

Keywords: matriptase, multiple myeloma, tumor suppressor, migration, Src

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Christine Sanders, Jan-Frederic Lau, Dimo Dietrich, Sebastian Strieth, Peter Brossart, Glen Kristiansen

Published Oct 14, 2022 · Vol. 13, No. 1 · pp. 1166-1173

Keywords: Nectin-4, enfortumab-vedotin, HNSCC, p16

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum

Marcel Kemper, Georg Evers, Arik Bernard Schulze, Jan Sperveslage, Christoph Schülke, Georg Lenz, Thomas Herold, Wolfgang Hartmann, Hans-Ulrich Schildhaus, Annalen Bleckmann

Published Oct 13, 2022 · Vol. 13, No. 1 · pp. 1216-1216

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Proof-of-principle: targeted childhood leukemia prevention Editorial

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction

Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 Research Paper

Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD) Research Paper

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients Research Paper

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer Retraction

Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention Research Paper

Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function Editorial

Proof-of-principle: targeted childhood leukemia prevention Editorial

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction

Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 Research Paper

Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD) Research Paper

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients Research Paper

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Retraction: Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer Retraction

Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention Research Paper

Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more Review

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer Research Paper

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum